Displaying drugs 14326 - 14350 of 14705 in total
(S)-famoxadone
Experimental
2-chloro-5-nitro-N-phenylbenzamide
Experimental
2,6-dibromo-4-phenoxyphenol
Experimental
N-phenyl-1H-pyrazole-3-carboxamide
Experimental
2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE
Experimental
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. 5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole targets the protein genome polyprotein.
Experimental
2-(4-METHOXYPHENYL)ACETAMIDE
Experimental
4-(2-AMINOETHYL)BENZENESULFONAMIDE
Experimental
Ponazuril
Ponazuril, sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.
Vet approved
Displaying drugs 14326 - 14350 of 14705 in total